Clinical Trial Update: Interleukin-15 to Promote Post-ART Control of HIV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating interleukin-15 to promote post-ART control of HIV. The study is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Interleukin-15 (interleukin-15)

Snippet

Sponsor: Michael Peluso, MD | Conditions: HIV | Phase 2 | Status: ENROLLING_BY_INVITATION